Latest news
Loading news…
Seres Therapeutics
ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 HighHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 Low growthGrowth score — momentum trend across web traffic, headcount and other growth signals. Cambridge, Massachusetts, United States Founded 2010 101-250 employees For Profit
Seres Therapeutics is a microbiome therapeutics company that develops treatments for serious diseases.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
393
Ticker
MCRB
NASDAQ
Patents
46
16 trademarks
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Public
- Ticker
- MCRB
- Exchange
- NASDAQ
- IPO date
- Jun 26, 2015
- Raised at IPO
- $133M
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 18
- Active products
- 22
- Patents granted
- 46
- Trademarks
- 16
- Top patent class
- Medical Or Veterinary Science; Hygiene
- IT spend
- $3M
Company Info
- Founded
- 2010
- Employees
- 101-250
- Operating status
- Active
- Company type
- For Profit
- Org types
- company
- Founders
- 2
- News articles
- 228
- Events
- 1
- HQ
- Cambridge, Massachusetts, United States
- Region
- Greater Boston Area, East Coast, New England
- Exit date
- Jun 26, 2015
Signals & Scores
- Heat score
- High
- Growth score
- Low
- Trend (7d)
- -0.3
- Trend (30d)
- 2.2
- Trend (90d)
- 7
- Last leadership hire
- Mar 6, 2026
- Last layoff mention
- Feb 12, 2026
Key People at Seres Therapeutics
Executive Vice President and Chief People Officer
EVP, Chief People Officer
CFO
Executive VP, Chief Scientific Officer
Executive Chair and Interim Chief Executive Officer
CFO and Head of Business Development
393
professional contacts at Seres Therapeutics
Contact execs at Seres Therapeutics →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Seres Therapeutics
Loading news…
FAQs about Seres Therapeutics
People who checked this page also checked these
Browse the full Acquirezy directory.